Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis Defined Benefit Obligation in the United States by Year
Defined Benefit Obligation (DBO) in the United States ($M)
Novartis Defined Benefit Obligation in the United States: $2,408M in FY2025, up 1.4% from a year earlier.
Latest, FY2025
2,408
Period ended Dec 31, 2025
Change on a year earlier
+1.4%
2,374 in FY2024
History
3 years
Since FY2023
Sources
2
Documents cited below
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F Note 25.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Defined Benefit Obligation (DBO) in the United States ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,408 | +1.4% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 2,374 | -7.8% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 2,574 | – | Novartis Form 20-F (0001370368-25-000004) ↗ |
Cite this data
StockData. (2026). Novartis Defined Benefit Obligation in the United States ($M), annual FY2023–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/pension-dbo-us
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.